Skip to main content
Premium Trial:

Request an Annual Quote

Celera to Distribute AlphaGene s cDNA Database

NEW YORK, Nov. 13 - AlphaGene announced Tuesday that it had entered into an agreement with Celera Genomics, which will distribute AlphaGene's set of full-length human clones.

 

Celera will make this data available through its subscription database both to academic and commercial researchers.

 

By the terms of the agreement, AlphaGene will isolate known clones from public databases. Celera will map those clone sequences to its human genome database.

 

AlphaGene, a Woburn, Mass.-based functional genomics company, will also be responsible for sequencing and manufacturing the clones.

 

Financial terms of the agreement were not disclosed, although Celera will market the effort.

The company focuses on gene expression in degenerative neurological diseases like Parkinson's and Alzheimer's, and has constructed more than 200 cDNA libraries from major organs and tissues in the body. More than half of the gene inventory is derived from neurological tissue.

 

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.